This is a pilot randomized control trial randomizing patients presenting in opioid withdrawal
to the emergency department to receive either one of clonidine (usual standard of care) or
buprenorphine for their opioid withdrawal. Primary treatment outcome is attendance at a rapid
access addiction medicine clinic within a few days of emergency room presentation. Secondary
treatment outcome is treatment status with respect to opioid agonist treatment at one month
post emergency room visit.